[{"address1": "21925 W. Field Parkway", "address2": "Suite 235", "city": "Deer Park", "state": "IL", "zip": "60010-7278", "country": "United States", "phone": "847 787 7361", "website": "https://www.etonpharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, and commercializing pharmaceutical products for rare diseases. The company offers INCRELEX, treatment for children who suffer from severe primary insulin-like growth factor 1 deficiency (SPIGFD); ALKINDI SPRINKLE, as a replacement therapy for Adrenocortical Insufficiency (\u0093AI\u0094) in children under 17 years of age, and accurate dosing for newborns and children with AI; GALZIN, as a maintenance treatment for patients with Wilson Disease who have been initially treated with a chelating agent; PKU GOLIKE, medical formula for the dietary management of phenylketonuria (\u0093PKU\u0094); Carglumic Acid, treatment of acute and chronic hyperammonemia due to N-acetylglutamate synthase (\u0093NAGS\u0094) deficiency; Betaine Anhydrous, for the treatment of homocystinuria; Nitisinone for the treatment of tyrosinemia type 1; and Amglidia for the treatment of neonatal diabetes mellitus products. It also develops ET-600 for the treatment of central diabetes insipidus; ET-700 for the treatment of treatment of Wilson disease; ET-800; Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.", "fullTimeEmployees": 31, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sean E. Brynjelsen", "age": 52, "title": "President, CEO & Director", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 939417, "exercisedValue": 0, "unexercisedValue": 1289502}, {"maxAge": 1, "name": "Mr. James R. Gruber CPA", "age": 51, "title": "CFO, Treasurer & Secretary", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 554442, "exercisedValue": 0, "unexercisedValue": 26099}, {"maxAge": 1, "name": "Mr. David C. Krempa", "age": 35, "title": "Chief Business Officer", "yearBorn": 1989, "fiscalYear": 2023, "totalPay": 547858, "exercisedValue": 0, "unexercisedValue": 318425}, {"maxAge": 1, "name": "Danka  Radosavljevic", "title": "Senior Vice President of Quality & Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Grossenbach", "title": "Senior Vice President of Sales Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin  Guthrie", "title": "Executive VP of Commercial Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ipek  Erdogan-Trinkaus", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 15.79, "open": 15.67, "dayLow": 15.2501, "dayHigh": 15.88, "regularMarketPreviousClose": 15.79, "regularMarketOpen": 15.67, "regularMarketDayLow": 15.2501, "regularMarketDayHigh": 15.88, "payoutRatio": 0.0, "beta": 1.343, "forwardPE": 29.849058, "volume": 100246, "regularMarketVolume": 100246, "averageVolume": 264177, "averageVolume10days": 233300, "averageDailyVolume10Day": 233300, "bid": 15.62, "ask": 15.91, "bidSize": 3, "askSize": 3, "marketCap": 424252832, "fiftyTwoWeekLow": 3.18, "fiftyTwoWeekHigh": 18.41, "priceToSalesTrailing12Months": 10.875211, "fiftyDayAverage": 14.2864, "twoHundredDayAverage": 10.24695, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 439311392, "profitMargins": -0.098000005, "floatShares": 20737195, "sharesOutstanding": 26817500, "sharesShort": 402632, "sharesShortPriorMonth": 235628, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.015, "heldPercentInsiders": 0.055710003, "heldPercentInstitutions": 0.4918, "shortRatio": 1.52, "shortPercentOfFloat": 0.015800001, "impliedSharesOutstanding": 26817500, "bookValue": 0.915, "priceToBook": 17.289618, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -3823000, "trailingEps": -0.15, "forwardEps": 0.53, "enterpriseToRevenue": 11.261, "enterpriseToEbitda": -397.207, "52WeekChange": 3.494318, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 15.82, "targetHighPrice": 33.0, "targetLowPrice": 24.0, "targetMeanPrice": 27.66667, "targetMedianPrice": 26.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 14936000, "totalCashPerShare": 0.557, "ebitda": -1106000, "totalDebt": 29994000, "quickRatio": 1.018, "currentRatio": 2.056, "totalRevenue": 39011000, "debtToEquity": 122.785, "revenuePerShare": 1.507, "returnOnAssets": -0.025290001, "returnOnEquity": -0.19161, "grossProfits": 23411000, "freeCashflow": -18781876, "operatingCashflow": 969000, "revenueGrowth": 0.593, "grossMargins": 0.60011, "ebitdaMargins": -0.028350001, "operatingMargins": 0.08964, "financialCurrency": "USD", "symbol": "ETON", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1745611514, "regularMarketTime": 1745611202, "exchange": "NGM", "messageBoardId": "finmb_435353222", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.18999197, "regularMarketPrice": 15.82, "marketState": "CLOSED", "shortName": "Eton Pharmaceuticals, Inc.", "longName": "Eton Pharmaceuticals, Inc.", "fiftyDayAverageChange": 1.5335999, "fiftyDayAverageChangePercent": 0.10734684, "twoHundredDayAverageChange": 5.5730495, "twoHundredDayAverageChangePercent": 0.54387397, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1542119400000, "postMarketChangePercent": 0.0, "postMarketPrice": 15.82, "postMarketChange": 0.0, "regularMarketChange": 0.029999733, "regularMarketDayRange": "15.2501 - 15.88", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 264177, "fiftyTwoWeekLowChange": 12.639999, "fiftyTwoWeekLowChangePercent": 3.9748425, "fiftyTwoWeekRange": "3.18 - 18.41", "fiftyTwoWeekHighChange": -2.5900002, "fiftyTwoWeekHighChangePercent": -0.14068443, "fiftyTwoWeekChangePercent": 349.4318, "earningsTimestamp": 1742295000, "earningsTimestampStart": 1746442200, "earningsTimestampEnd": 1747651800, "earningsCallTimestampStart": 1731447000, "earningsCallTimestampEnd": 1731447000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.15, "epsForward": 0.53, "epsCurrentYear": 0.4, "priceEpsCurrentYear": 39.55, "displayName": "Eton Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]